The management of renal cell carcinoma.
Pittman
K
K
ICRF Cancer Medicine Research Unit, St James's University Hospital Trust, Leeds, UK.
Selby
P
P
D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003374:Coumarins / Q000627:therapeutic use; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D009367:Neoplasm Staging; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D003374:Coumarins; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons; C030123:coumarin